Reply: Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- PMID: 31603183
- DOI: 10.1093/brain/awz294
Reply: Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
Comment on
-
Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.Brain. 2019 Nov 1;142(11):e59. doi: 10.1093/brain/awz293. Brain. 2019. PMID: 31603187 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
